Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Total HCV Franchise by Year
Total HCV Franchise (legacy sub-franchise breakout) ($M) ($M)
Gilead Sciences Total HCV Franchise: $1,767M in FY2023, down 2.4% from a year earlier. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
Source: Form 10-K (filed 2024-02-23) ↗
Reported in Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total HCV Franchise (legacy sub-franchise breakout) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 1,767 | -2.4% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 1,810 | -3.8% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 1,881 | -8.9% | Form 10-K (filed 2024-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 2,064 | -29.7% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 2,936 | -20.3% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 3,686 | – | Form 10-K (filed 2021-02-25) ↗ |
Breakdown
What makes up total HCV Franchise
- Total HCV Franchise (legacy sub-franchise breakout) — U.S. sales ($M)1,002 · FY2023
- Total HCV Franchise (legacy sub-franchise breakout) — Europe sales ($M)378 · FY2023
- Total HCV Franchise (legacy sub-franchise breakout) — Rest of World sales ($M)386 · FY2023
- Total HCV Franchise (legacy sub-franchise breakout) — Worldwide YoY growth (%)-4.0% · FY2022
- Ledipasvir / Sofosbuvir (Harvoni & authorized generic — legacy breakout) ($M)70 · FY2023
- Vosevi (sofosbuvir / velpatasvir / voxilaprevir — legacy breakout) ($M)257 · FY2019
- Other HCV (Sovaldi — legacy breakout) ($M)160 · FY2023
Cite this data
StockData. (2026). Gilead Sciences Total HCV Franchise ($M), annual FY2018–FY2023 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/liver-hcv-total
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.